On December 8, 2008, the law firm of Sarraf Gentile LLP commenced a securities fraud class action lawsuit on behalf of those investors who acquired the securities of Crystallex International Corporation ("Crystallex" or the "Company") (AMEX: KRY) during the period July 28, 2005 to April 30, 2008, inclusive (the "Class Period"). The lawsuit is pending in the United States District Court for the Southern District of New York and names as defendants Crystallex and certain of its former officers.

According to the complaint, the defendants made several statements during the Class Period about the Company's Las Cristinas Gold Project located in Sifontes, Venezuela, and that the issuance of the required Venezuelan government permit in connection with that project was imminent. The complaint alleges, however, that during the Class Period defendants did not have a reasonable expectation that the Company would receive the required permit and that on April 30, 2008, the permit was, in fact, denied. On news that the permit was denied, the complaint alleges, the Company's stock fell roughly from a closing price of $1.68 on April 29, 2008, to a closing price of $0.91on April 30, 2008, on heavy volume.

Plaintiffs are represented by the law firm of Sarraf Gentile LLP, which have extensive experience in the prosecution of class actions on behalf of investors.

If you bought the securities of Crystallex between July 28, 2005 and April 30, 2008, you may, no later than 60 days from today, move the Court to appoint you as lead plaintiff, a representative party that acts on behalf of other class members. The Court must determine whether the class member's claim is typical of other class members' claims, and whether the class member will adequately represent the class. Your ability to share in any recovery is not, however, affected by the decision whether or not to serve as a lead plaintiff. You may retain Sarraf Gentile LLP or other counsel of your choice, to serve as your counsel in this action.

If you would like to participate in this action or would like additional information about the lawsuit, please contact Joseph Gentile at Sarraf Gentile LLP, 11 Hanover Square, New York, NY 10005 (telephone: 212-868-3610; e-mail: joseph@sarrafgentile.com).

Contact: Joseph Gentile Email Contact SARRAF GENTILE LLP 11 Hanover Square New York, NY 10005 T 212.868.3610 F 212.918.7967 www.sarrafgentile.com

Crystallex (AMEX:KRY)
過去 株価チャート
から 6 2024 まで 7 2024 Crystallexのチャートをもっと見るにはこちらをクリック
Crystallex (AMEX:KRY)
過去 株価チャート
から 7 2023 まで 7 2024 Crystallexのチャートをもっと見るにはこちらをクリック